Major Depressive Disorder

Read about the new results from Sage’s clinical study of depression treatment, zuranolone.

There are epidemiological and clinical reasons why we should drop that term.

Dr Sanacora discusses the new indication for esketamine, SPRAVATO®, and how it might be used to treat patients with Major Depressive Disorder with acute risk of suicide ideation.

The pandemic has brought into focus treatment barriers, disruption in care, and possibly negative outcomes in the mental health of university students. To better understand the specific challenges of out-of-state students, the authors conducted an anonymous national survey of college psychiatrists.

Drug interactions, discontinuation issues, adverse effects, and more. These are the problems that are often overlooked.

These techniques may help promote self-efficacy and elicit patients’ commitment to resolve ambivalence about treatment.

The authors explore adjunctive treatments for MDD and their impact on overall medical costs and health care utilization.

The authors examine recent literature in order to assist psychiatrists in evaluating the findings and determining how to best put research findings into real-world practice.

Dr John Miller shows us one of his favorite topics to talk about and practice.

With most chronic pain conditions, the exact pathology is uncertain. In such cases, psychiatrists may be called to assess for illness beyond medical diagnosis.

Avicenna may have been among the first physicians to document that anger is often a transitional state from melancholic depression to mania—implicitly recognizing the “switch” phenomenon.

Fewer women than men with major depressive disorder experience symptom relief with antidepressants. Is there a role for alternative therapies?

A 59-year-old man with a history of multiple concussions has been having a series of neurocognitive symptoms for the past several years. Discover more in this case.

Findings underscore earlier data that indicate Americans are ready and willing to talk about mental health, plus guidance for clinicians who may have lost a patient or colleague to suicide.

Although they may have been the result of good intentions, these mistakes could adversely impact mother and baby.

Psychiatric leadership is essential to the success of efforts toward mitigating suicide risk. That said, can suicide be prevented? Take the quiz and learn more.

There are myriad nuanced clinical approaches to cancer treatment, and psychosocial factors are no less complex.

An added component of cancer treatment is discovering what is most meaningful in the patient’s life and using that to buoy them during difficult moments. That, in a nutshell, is the psychiatrist's role.

Two examples described here underscore the importance of understanding the cytochrome P450 (CYP) system

One can only hope today's challenges will become a “corrective emotional experience."

Women should be provided with multiple options for treatment if they decide to engage in mental health care during this critical period.

Are patients with cancer also vulnerable to PTSD?

It is much easier to treat depression after 6 months of non-response than 6 years, regardless of which intervention is used, so time is of the essence.

Drug mechanisms of action are evolving. An area in psychiatry that has become increasingly important clinically is discussed here.

As the pandemic lingers, managing depression can become that much more difficult. These proven steps can help patients, and you, better manage depression.

Some speculate the pharmaceutical industry has virtually abandoned new drug development in neuroscience with a few exceptions. However, it should be noted that progress has been made.

Despite advances in clinical care for patients with cancer, distress and depression continue to haunt patients. These fast facts will help you better understand and care for patients with cancer.

Inevitably, some of your patients will need of emergency psychiatric services. These tips will help prepare you and your patients when a crisis unfolds.

While only a minority of patients with cancer may have diagnosable PTSD, subthreshold symptoms in some patients may be debilitationg enough that clinicians should be aware of the phenomenon.

The articles in Part I of this Special Report discuss PTSD in cancer, special issues for patients with schizophrenia and cancer, and distress management.